Kodiak Sciences (KOD)
(Delayed Data from NSDQ)
$3.74 USD
0.00 (0.00%)
Updated May 16, 2024 04:00 PM ET
After-Market: $3.72 -0.02 (-0.53%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth C Momentum C VGM
Brokerage Reports
Kodiak Sciences Inc. [KOD]
Reports for Purchase
Showing records 41 - 60 ( 125 total )
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Healthcare Coverage Update - Dropping Coverage
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
ARVO, the Global Ophthalmology Meeting Begins on Sunday, May 1st in Denver
Provider: Roth Capital Partners, Inc.
Analyst: JALLAH Z
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Eyes Wide Open - Lowering PT To $75 from $149, but Remaining Buy Rated.
Provider: Roth Capital Partners, Inc.
Analyst: JALLAH Z
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Tracking Towards a 2023 BLA Filing -Could Be Worth Another Look - $149 PT
Provider: Roth Capital Partners, Inc.
Analyst: JALLAH Z
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
3Q21 Update - Pivotal Readouts Expected in 2022/2023 to Support BLA Filing
Provider: Roth Capital Partners, Inc.
Analyst: JALLAH Z